Therapy | Types of malignancy | Responder | Non-responder | References |
---|---|---|---|---|
Anti-PD1 | NSCLC | Akkermansia muciniphila, Enterococcus hirae | Â | Routy et al. [163] |
Anti-PD1 | Melanoma | Faecalibacterium | Bacteroidales | Gopalakrishnan et al. [166] |
Anti-PD1 | Metastatic melanoma | Bifidobacterium longum, Collinsella aerofaciens, and Enterococcus faecium | Ruminococcus obeum, Roseburia intestinalis | Matson et al. [167] |
Anti-CTLA4 | Metastatic melanoma | Firmicutes phylum, e.g. Faecalibacterium | – | Chaput et al. [201] |
Anti-CTLA4 Anti-PD1 | Metastatic melanoma | Bacteroides caccae, Streptococcus parasanguinis | – | Frankel et al. [265] |
Anti-CTLA4 Anti-PD1 | Metastatic melanoma | Faecalibacterium prausnitzii, Holdemania filiformis, Bacteroides thetaiotamicron | – | Frankel et al. [265] |
Pembrolizumab | Metastatic melanoma | Dorea formicigenerans | – | Frankel et al. [265] |